Pathological measurement and staging of residual breast cancer after neoadjuvant chemotherapy.

Harter, Dawn; O'Connor, Siobhan M; Hertel, Johann D; Calhoun, Benjamin C

Harter, Dawn; O'Connor, Siobhan M; Hertel, Johann D; Calhoun, Benjamin C.

Afiliação

Harter D; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
O'Connor SM; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Hertel JD; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Calhoun BC; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Histopathology ; 83(3): 453-464, 2023 Sep.

Article em En | MEDLINE | ID: mdl-37256703

Assuntos

Neoplasias da Mama; Neoplasias de Mama Triplo Negativas; Humanos; Feminino; Neoplasias da Mama/patologia; Terapia Neoadjuvante/métodos; Neoplasias de Mama Triplo Negativas/patologia; Neoplasia Residual/tratamento farmacológico; Neoplasia Residual/patologia; Receptor ErbB-2/uso terapêutico; Mama/patologia; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Quimioterapia Adjuvante; Estadiamento de Neoplasias; Estudos Retrospectivos

Palavras-chave

AJCC; RCB; breast; chemotherapy; neoadjuvant; pathology; residual cancer burden; staging

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neoplasias de Mama Triplo Negativas Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google